| Literature DB >> 27494666 |
Wen Cai Zhang1, Frank J Slack2.
Abstract
Leukemic stem cells (LSCs) drive progression of chronic myeloid leukemia (CML) and tyrosine kinase inhibitor resistance through poorly understood mechanisms. Now in Cell Stem Cell, Zipeto et al. (2016) show targeting the RNA editing enzyme ADAR1 restores expression of let-7 and efficiently kills LSCs, providing an innovative therapeutic target in CML.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27494666 DOI: 10.1016/j.stem.2016.07.012
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633